BDX
Becton Dickinson and Company
NYSE: BDX · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$145.31
-2.82% today
Updated 2026-04-29
Market cap
$43.28B
P/E ratio
24.86
P/S ratio
1.97x
EPS (TTM)
$6.12
Dividend yield
2.69%
52W range
$125 – $186
Volume
2.7M
Becton Dickinson and Company (BDX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.74B | $6.36B | $7.07B | $6.99B | $7.12B | $7.58B | $7.71B | $8.05B | $8.45B | $10.28B | $12.48B | $12.09B | $15.98B | $17.29B | $16.07B | $19.13B | $18.87B | $19.37B | $20.18B | $21.84B |
| Revenue growth (YoY) | — | +10.8% | +11.2% | -1.2% | +2.0% | +6.5% | +1.6% | +4.5% | +4.9% | +21.7% | +21.4% | -3.1% | +32.2% | +8.2% | -7.0% | +19.0% | -1.4% | +2.7% | +4.2% | +8.2% |
| Cost of revenue | $2.79B | $3.07B | $3.45B | $3.31B | $3.43B | $3.63B | $3.75B | $3.88B | $4.14B | $5.59B | $6.49B | $6.13B | $8.71B | $9.00B | $9.28B | $10.50B | $10.39B | $11.20B | $11.05B | $11.91B |
| Gross profit | $2.94B | $3.29B | $3.63B | $3.68B | $3.70B | $3.96B | $3.95B | $4.17B | $4.30B | $4.70B | $5.99B | $5.96B | $7.27B | $8.29B | $6.80B | $8.63B | $8.48B | $8.17B | $9.13B | $9.92B |
| Gross margin | 51.3% | 51.7% | 51.3% | 52.6% | 51.9% | 52.2% | 51.3% | 51.8% | 50.9% | 45.7% | 48.0% | 49.3% | 45.5% | 47.9% | 42.3% | 45.1% | 44.9% | 42.2% | 45.2% | 45.4% |
| R&D | $301.87M | $360.05M | $395.63M | $404.57M | $422.77M | $470.00M | $472.00M | $494.00M | $550.00M | $632.00M | $828.00M | $770.00M | $1.00B | $1.06B | $1.04B | $1.28B | $1.26B | $1.24B | $1.19B | $1.26B |
| SG&A | $1.54B | $1.60B | $1.72B | $1.70B | $1.72B | $1.85B | $1.92B | $2.42B | $2.15B | $2.56B | $3.00B | $44.00M | $13.00M | $2.00M | $7.00M | $1.00M | $4.71B | $4.72B | $4.86B | $5.28B |
| Operating income | $1.14B | $1.20B | $1.54B | $1.59B | $1.58B | $1.67B | $1.56B | $1.25B | $1.61B | $1.07B | $1.43B | $1.52B | $1.51B | $1.76B | $912.00M | $2.25B | $2.28B | $2.11B | $2.40B | $2.58B |
| Operating margin | 19.9% | 18.9% | 21.7% | 22.8% | 22.2% | 22.0% | 20.2% | 15.6% | 19.0% | 10.4% | 11.5% | 12.6% | 9.4% | 10.2% | 5.7% | 11.8% | 12.1% | 10.9% | 11.9% | 11.8% |
| EBITDA | $1.60B | $1.77B | $2.05B | $2.08B | $2.11B | $2.20B | $2.12B | $1.85B | $2.22B | $2.00B | $2.58B | $2.58B | $3.86B | $4.07B | $3.06B | $4.39B | $4.41B | $4.40B | $4.82B | $4.96B |
| EBITDA margin | 27.8% | 27.8% | 29.0% | 29.8% | 29.6% | 29.0% | 27.5% | 23.0% | 26.3% | 19.5% | 20.6% | 21.4% | 24.1% | 23.5% | 19.0% | 23.0% | 23.4% | 22.7% | 23.9% | 22.7% |
| EBIT | $1.19B | $1.33B | $1.57B | $1.62B | $1.62B | $1.70B | $1.61B | $1.30B | $1.66B | $1.11B | $1.46B | $1.50B | $1.88B | $1.81B | $942.00M | $2.16B | $2.18B | $2.11B | $2.53B | $2.50B |
| Interest expense | $0.00 | $0.00 | $36.34M | $40.39M | $51.26M | $84.00M | $135.00M | $138.00M | $135.00M | $371.00M | $388.00M | $521.00M | $706.00M | $639.00M | $528.00M | $469.00M | $398.00M | $452.00M | $528.00M | $613.00M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $752.28M | $890.03M | $1.13B | $1.23B | $1.32B | $1.27B | $1.17B | $1.29B | $1.19B | $695.00M | $976.00M | $1.10B | $311.00M | $1.23B | $874.00M | $2.09B | $1.78B | $1.48B | $1.71B | $1.68B |
| Net income growth (YoY) | — | +18.3% | +26.6% | +9.3% | +7.0% | -3.5% | -7.9% | +10.5% | -8.4% | -41.4% | +40.4% | +12.7% | -71.7% | +296.5% | -29.1% | +139.4% | -15.0% | -16.6% | +14.9% | -1.6% |
| Profit margin | 13.1% | 14.0% | 15.9% | 17.6% | 18.5% | 16.8% | 15.2% | 16.1% | 14.0% | 6.8% | 7.8% | 9.1% | 1.9% | 7.1% | 5.4% | 10.9% | 9.4% | 7.7% | 8.4% | 7.7% |